BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dordaviprone readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Dordaviprone\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04055649-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20270528
DTEND;VALUE=DATE:20270529
SUMMARY:Dordaviprone: Phase 2 readout est. (NCT04055649)
DESCRIPTION:Dordaviprone\, phase 2.\nStudy: ONC201 Plus Weekly Paclitaxel i
 n Patients With Platinum Refractory or Resistant Ovarian Cancer\nEstimated
  primary completion: 28 May 2027. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/dordaviprone#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT04055649
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05009992-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Dordaviprone: Phase 2 readout est. (NCT05009992)
DESCRIPTION:Dordaviprone\, phase 2\, Glioma.\nStudy: Combination Therapy fo
 r the Treatment of Diffuse Midline Gliomas\nEstimated primary completion: 
 31 December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/dor
 daviprone#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT05009992
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05542407-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20280221
DTEND;VALUE=DATE:20280222
SUMMARY:Dordaviprone: Phase 1 readout est. (NCT05542407)
DESCRIPTION:Dordaviprone\, phase 1.\nStudy: ONC201 and Atezolizumab in Obes
 ity-Driven Endometrial Cancer\nEstimated primary completion: 21 February 2
 028. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/dordaviprone#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0554240
 7
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05580562-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Dordaviprone: Phase 3 readout est. (NCT05580562)
DESCRIPTION:Dordaviprone\, phase 3\, Glioma.\nStudy: ONC201 in H3 K27M-muta
 nt Diffuse Glioma Following Radiotherapy (the ACTION Study)\nEstimated pri
 mary completion: June 2028. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/dordaviprone#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT05580562
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05630794-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20280701
DTEND;VALUE=DATE:20280702
SUMMARY:Dordaviprone: Phase 1 readout est. (NCT05630794)
DESCRIPTION:Dordaviprone\, phase 1.\nStudy: Testing for Safety and Colorect
 al Cancer Preventive Effects of ONC201\nEstimated primary completion: 1 Ju
 ly 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/dordaviprone
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT056
 30794
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05476939-3224@assetmemo.bio
DTSTAMP:20261121T004101Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:Dordaviprone: Phase 3 readout est. (NCT05476939)
DESCRIPTION:Dordaviprone\, phase 3\, Glioma.\nStudy: Biological Medicine fo
 r Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0\nEstimated prima
 ry completion: September 2028. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/dordaviprone#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT05476939
URL:https://assetmemo.bio/drug/dordaviprone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
